Similarly, the transcription factor BHLHE40 reportedly enhances AMPK signaling by downregulating the phosphatase PPM1F, shifting tumor metabolism from glycolysis to oxidative phosphorylation [31]. Here, BHLHE40 is linked to neoplasm.